.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
Complimentary print subscription for home or office delivery
In-person and virtual events just for HCPs
Lively expert panel discussions featuring peer-to-peer exchanges
Subscribe to our eNewsletter for breaking news and curated content

SpecialtySee All >

Breast Cancer
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Hematopoietic Stem Cell Transplant: Infection Control

EP. 1: Burden of CMV Infection in HSCT Patients

January 18th 2018

EP. 2: Preemptive Therapy For CMV Reactivation in HSCT

January 18th 2018

EP. 3: Letermovir as CMV Prophylaxis in HSCT Patients

January 18th 2018

EP. 4: Practical Considerations for Administering Letermovir

January 18th 2018

EP. 5: Ongoing Research for CMV Management in HSCT Patients

January 18th 2018

EP. 6: Prevalence and Risk Factors for CMV Infection

January 18th 2018

EP. 7: Risk Stratification in CMV Infection

January 18th 2018

EP. 8: Current Strategies for Managing CMV Infection

January 18th 2018

EP. 9: Monitoring Patients and Initiating Treatment in CMV

January 18th 2018

EP. 10: Research Findings in CMV Infection

January 18th 2018

EP. 11: Considerations for Utilizing Letermovir in Practice

January 18th 2018

EP. 12: Addressing Unmet Needs in CMV Infection

January 18th 2018